Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-03-16

Clinical Trial Update: Resection+Highly Purified CTL Versus Resection Alone for HCC [Phase 3]

View source ↗

Summary

Phase 3 trial compares resection plus Highly Purified Cytotoxic T Lymphocytes (CTLs) versus resection alone for hepatocellular carcinoma. The current status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Highly Purified CTL (Cytotoxic T Lymphocytes)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: UNKNOWN